BGC4
BGC4 is a biphenyl-derived gold (III) complex that acts as a thioredoxin reductase (TrxR) inhibitor with an IC50 of 10.7 μM. It demonstrates potent in vitro cytotoxicity (IC50 = 5.4 μM in MDA-MB-231 cells) by inducing apoptosis and has shown promising antitumor efficacy in mouse xenograft models.
Product Specifications
Field of Research
Cell Biology
Molecular Formula
C30H32AuClF3N3
Molecular Weight
724.01
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
ABC-X2766 1 Vial
Xpress™ Human SDCCAG8 Over-expressing Stable Cell Line
Sign In for Pricing
View Details 
RC211697L4V 200 µL
PAP2D (PLPPR5) (NM_001037317) Human Tagged ORF Clone Lentiviral Particle
Sign In for Pricing
View Details 
OR1053328-01 250 mg
((2R,3S,4R,5R) -5- (6-Amino-9H-purin-9-yl) -3,4-dihydroxytetrahydrofuran-2-yl) methyl 4-methylbenzenesulfonate
Sign In for Pricing
View Details OR1053328-02 1 g
((2R,3S,4R,5R) -5- (6-Amino-9H-purin-9-yl) -3,4-dihydroxytetrahydrofuran-2-yl) methyl 4-methylbenzenesulfonate
Sign In for Pricing
View Details OR1053328-03 25 g
((2R,3S,4R,5R) -5- (6-Amino-9H-purin-9-yl) -3,4-dihydroxytetrahydrofuran-2-yl) methyl 4-methylbenzenesulfonate
Sign In for Pricing
View Details